JPMorgan Chase & Co analyst have initiated coverage on Booz Allen Hamilton Holding Corporation (NYSE:BAH) shares in the note issued to the investors. The firm has assigned a rating of “overweight” on the company stock and a price target of $23.00 on the stock. Booz Allen Hamilton Holding Corporation (NYSE:BAH) stock opened at $20.92 in last session, and closed at $21.03, while the day range of Booz Allen Hamilton Holding Corporation (NYSE:BAH) stock is $20.85 – $21.19. The stock showed a positive weekly performance of 2.49%.
Towers Watson & Co. (NYSE:TW) had its price objective reduced by Deutsche Bank from $125.00 to $120.00 in a report released on Thursday, American Banking and Market News reports. Deutsche Bank currently has a buy rating on the stock. Towers Watson & Co (NYSE:TW) stock opened at $107.60 in last session, and closed at $109.10 by gaining 1.72%. The 52 week range of $65.46 – $31.73. Company’s market capitalization is $7.73B.
Accretive Health, Inc. (NYSE:AH) has announced the appointment of Patrick Funck as senior vice president and chief information officer. Accretive Health, Inc. (NYSE:AH) stock decreased -2.01% and finished the last session at $8.28. The EPS of the stock remained 0.17. Company’s market capitalization is $815.50M.
FTI Consulting Inc. (NYSE:FCN) stock had its “neutral” rating reiterated by Zacks in a research note issued to investors on Wednesday, ARN reports. They currently have a $30.00 target price on the stock. Zacks‘s price objective points to a potential upside of 1.69% from the company’s current price. FTI Consulting, Inc. (NYSE:FCN) stock opened the session at $29.48, and closed the session at $29.19. The 52 week range of the FTI Consulting, Inc. (NYSE:FCN) stock remained $28.23 – $46.73 and the day range was $29.17 – $29.57.